About Us
Medesign is a Canadian research-driven design initiative specializing in the creation of customized 3D-printed biomedical prosthetics.
Our project is currently in its foundational stage, where we focus on developing the underlying technology that will support
future manufacturing
and distribution.
Our team integrates industrial design expertise with biomedical research to rethink how prosthetic devices are conceived.
We approach each design challenge with long-term clinical relevance, patient comfort, and material efficiency in mind.
PHASE 1 — Design & Engineering
We are currently collaborating with the Department of Biomedical Computing at Queen's University to develop early-stage prosthetic models.
This phase includes:
​
​​​• Conceptual and structural design. ​
• Material research and mechanical performance studies.
• Digital modelling and prototyping through 3D printing.
Our Develpment Phases
PHASE 2 — Clinical Evaluation
Once the prototypes are ready, they will be tested through clinical trials under approved research protocols.
This stage ensures:
• Functional testing.
• Patient feedback and ergonomic evaluation.
• Iterative refinement based on real-world use.
PHASE 3 — Manufacturing
Upon successful validation of the technology, Medesign will transition into the manufacturing phase.
​
Possible pathways include:​
• In-house production using advanced additive manufacturing systems.
• Partnerships with biomedical manufacturers.
• Scalable production methods to ensure quality and affordability.
Our long-term goal is to bring patient-specific prosthetic solutions
to families who need them—equipped with the flexibility,
adaptability and precision that modern 3D printing can offer.